Effect of Antithrombotic Therapy on Bleeding after Argon Plasma Coagulation for Gastric Neoplasms
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Postprocedural bleeding is known to be relatively low after argon plasma coagulation (APC) for gastric neoplasms; however, there are few studies proving the effect of antithrombotic agents. This study aimed to analyze the incidence of delayed bleeding (DB) based on antithrombotic agents administered and to identify the risk factors for DB in APC for gastric tumors. Methods: A total of 785 patients with 824 lesions underwent APC for single gastric neoplasm between January 2011 and January 2018. After exclusion, 719 and 102 lesions were classified as belonging to the non-antithrombotics (non-AT) and AT groups, respectively. The clinical outcomes were compared between the two groups, and we determined the risk factors for DB in gastric APC. Results: Of the total 821 cases, DB occurred in 20 cases (2.4%): 17 cases in the non-AT group and three cases in the AT group (2.4% vs 2.9%, p=0.728). Multivariate analysis of the risk factors for DB confirmed the following significant, independent risk factors: male sex (odds ratio, 7.66; 95% confidence interval, 1.02 to 57.69; p=0.048) and chronic kidney disease (odds ratio, 4.51; 95% confidence interval, 1.57 to 13.02; p=0.005). Thromboembolic events and perforation were not observed in all patients regardless of whether they took AT agents. Conclusions: AT therapy is acceptably safe in gastric APC because it does not significantly increase the incidence of DB. However, patients with chronic kidney disease or male sex need to receive careful follow-up on the incidence of post-APC bleeding.
Abstract
Background/Aims: Postprocedural bleeding is known to be relatively low after argon plasma coagulation (APC) for gastric neoplasms; however, there are few studies proving the effect of antithrombotic agents. This study aimed to analyze the incidence of delayed bleeding (DB) based on antithrombotic agents administered and to identify the risk factors for DB in APC for gastric tumors. Methods: A total of 785 patients with 824 lesions underwent APC for single gastric neoplasm between January 2011 and January 2018. After exclusion, 719 and 102 lesions were classified as belonging to the non-antithrombotics (non-AT) and AT groups, respectively. The clinical outcomes were compared between the two groups, and we determined the risk factors for DB in gastric APC. Results: Of the total 821 cases, DB occurred in 20 cases (2.4%): 17 cases in the non-AT group and three cases in the AT group (2.4% vs 2.9%, p=0.728). Multivariate analysis of the risk factors for DB confirmed the following significant, independent risk factors: male sex (odds ratio, 7.66; 95% confidence interval, 1.02 to 57.69; p=0.048) and chronic kidney disease (odds ratio, 4.51; 95% confidence interval, 1.57 to 13.02; p=0.005). Thromboembolic events and perforation were not observed in all patients regardless of whether they took AT agents. Conclusions: AT therapy is acceptably safe in gastric APC because it does not significantly increase the incidence of DB. However, patients with chronic kidney disease or male sex need to receive careful follow-up on the incidence of post-APC bleeding.
참고문헌 (29)
- Grund KE, "Endoscopic argon plasma coagulation(APC)first clinical experiences in flexible endoscopy", Endosc Surg Allied Technol, 2, pp.42~46 (1994)
- Wahab PJ, "Argon plasma coagulation in flexible gastrointestinal endoscopy : pilot experiences", Endoscopy, 29, pp.176~181 (1997)
- Grund KE, "Argon plasma coagulation through a flexible endoscope : evaluation of a new therapeutic method after 1606 uses", Dtsch Med Wochenschr, 122, pp.432~438 (1997)
- Sagawa T, "Argon plasma coagulation for successful treatment of early gastric cancer with intramucosal invasion", Gut, 52, pp.334~339 (2003)
- Jung SJ, "Argon plasma coagulation is safe and effective for treating smaller gastric lesions with low-grade dysplasia : a comparison with endoscopic submucosal dissection", Surg Endosc, 27, pp.1211~1218 (2013)
- Ahn JY, "Clinical outcomes of argon plasma coagulation for the treatment of gastric neoplasm", Surg Endosc, 27, pp.3146~3152 (2013)
- Akhtar K, "Argon beam plasma coagulation in the management of cancers of the esophagus and stomach", Surg Endosc, 14, pp.1127~1130 (2000)
- Manner H, "Safety and efficacy of a new high power argon plasma coagulation system(hp-APC)in lesions of the upper gastrointestinal tract", Dig Liver Dis, 38, pp.471~478 (2006)
- Kim B, "Cost-effectiveness and short-term clinical outcomes of argon plasma coagulation compared with endoscopic submucosal dissection in the treatment of gastric low-grade dysplasia", Medicine(Baltimore), 97, pp.e0330~ (2018)
- 이동현, "The Usefulness of Argon Plasma Coagulation Compared with Endoscopic Submucosal Dissection to Treat Gastric Adenoma", 대한소화기학회지, 69(5), pp.283~290 (2017), 대한소화기학회
- ASGE Standards of Practice Committee, "The management of antithrombotic agents for patients undergoing GI endoscopy", Gastrointest Endosc, 83, pp.3~16 (2016)
- Chan FKL, "Management of patients on antithrombotic agents undergoing emergency and elective endoscopy : joint Asian Pacific Association of Gastroenterology(APAGE)and Asian Pacific Society for Digestive Endoscopy(APSDE)practice guidelines", Gut, 67, pp.405~417 (2018)
- Na S, "Delayed bleeding rate according to the forrest classification in second-look endoscopy after endoscopic submucosal dissection", Dig Dis Sci, 60, pp.3108~3117 (2015)
- Park SE, "Risk factors and correlations of immediate, early delayed, and late delayed bleeding associated with endoscopic resection for gastric neoplasms", Surg Endosc, 30, pp.625~632 (2016)
- Tounou S, "Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy", Endosc Int Open, 3, pp.E31~E38 (2015)
- Chau CH, "Randomized controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers", Gastrointest Endosc, 57, pp.455~461 (2003)
- Iacopini F, "Hemostasis of Dieulafoy’s lesions by argon plasma coagulation(with video)", Gastrointest Endosc, 66, pp.20~26 (2007)
- Kwan V, "Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions : experience in 100 consecutive patients with long-term follow-up", Am J Gastroenterol, 101, pp.58~63 (2006)
- Canard JM, "Clinical application of argon plasma coagulation in gastrointestinal endoscopy : has the time come to replace the laser", Endoscopy, 33, pp.353~357 (2001)
- Watson JP, "The tissue effect of argon plasma coagulation on esophageal and gastric mucosa", Gastrointest Endosc, 52, pp.342~345 (2000)
- Lee KM, "Argon plasma coagulation with submucosal saline injection for gastric adenoma on outpatient basis", Dig Dis Sci, 54, pp.2623~2628 (2009)
- Kearon C, "Antithrombotic therapy for venous thromboembolic disease : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th edition)", Chest, 133(6 Suppl), pp.454S~545S (2008)
- Antithrombotic Trialists’ Collaboration, "Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients", BMJ, 324, pp.71~86 (2002)
- Libânio D, "Risk factors for bleeding after gastric endoscopic submucosal dissection : a systematic review and meta-analysis", Gastrointest Endosc, 84, pp.572~586 (2016)
- Jeon SW, "Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions", Surg Endosc, 23, pp.1974~1979 (2009)
- Cho SJ, "Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms", Endoscopy, 44, pp.114~121 (2012)
- Kono Y, "Postoperative bleeding risk after gastric endoscopic submucosal dissection during antithrombotic drug therapy", J Gastroenterol Hepatol, 33, pp.453~460 (2018)
- Igarashi K, "Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection", Surg Endosc, 31, pp.1746~1753 (2017)
- Numata N, "Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease", J Gastroenterol Hepatol, 28, pp.1632~1637 (2013)
